DYRK2 and neuroblastoma: Besides, treating neuroblastoma cell lines with LDN-192960, a DYRK2 inhibitor, resulted in a high cytotoxic effect suggesting a key role for DYRK2 in the survival of tumoral cells (Uhl et al., 2018).